comparitive study of two antifungal medicines in treatment of superficial fungal infection
Not yet recruiting
- Conditions
- Fungal infected stable patients.
- Registration Number
- CTRI/2018/07/015063
- Lead Sponsor
- IMS BHU
- Brief Summary
this is a comparative study with two drugs (terbinafine and itraconazole) with recommended daily doses, double daily doses and combination of both drugs with daily doses. Total study period is of 8 weeks.
primary and secondary outcomes are complete clearing of skin lesions.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- All
- Target Recruitment
- 275
Inclusion Criteria
Tinea cruris Tinea corporis Tinea faciei.
Exclusion Criteria
- weight more than 80 kg Any other co-morbidities like hepatic disorders, renal disorders, cardiac disorders, etc.
- history of oral antifungal agents within one month of start of study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Complete clearance of skin lesions every 2 weeks for 8 weeks
- Secondary Outcome Measures
Name Time Method Experienced as primary outcome. Every 2 weeks for 8 weeks.
Trial Locations
- Locations (1)
Sir Sunderlal Hospital
🇮🇳Varanasi, UTTAR PRADESH, India
Sir Sunderlal Hospital🇮🇳Varanasi, UTTAR PRADESH, IndiaNajuma SubbaPrincipal investigator9198120582najumasubba@gmail.com